270 articles
Go beneath the surface of cellular alarm signaling — explore the receptor subtypes, enzymatic pathways, and feedback loops that determine whether ATP triggers inflammation or resolution in aging tissue.
A clinical guide to interpreting microbiome and high-plex proteomic reports — what each layer actually measures, how much weight it deserves, and why convergence across independent layers is the only signal strong enough to act on.
Discover how your cells send out tiny chemical SOS messages when under stress — and why this ancient communication system is a key player in how we age.
A practical framework for sequencing advanced imaging in preventive practice: why a picture of disease outranks a score that predicts it, where coronary calcium goes blind in younger patients, and how to weigh whole-body MRI's occult cancers against its cascades.
Master the cutting-edge science of fibrinolytic dysfunction — from SERPINE1 epigenetics and senescence feedback loops to emerging PAI-1 inhibitors and precision protocols for restoring clot-clearance capacity.
A clinical guide to interpreting genetic risk alongside blood biomarkers in cardiovascular prevention — why apoB beats LDL-C, where Lp(a) fits, how to catch insulin resistance a decade early, and why a laboratory reference range is not a target.
Go beyond the basics: explore the molecular machinery of fibrinolysis, how PAI-1 expression is regulated at the cellular level, and why fibrinolytic aging is a multisystem phenomenon with real cardiovascular consequences.
A clinical guide to what common single-nucleotide variants and curated panels genuinely deliver — pharmacogenomic phenotypes, HLA risk types, polygenic percentiles — and the structural reasons a negative panel in a symptomatic patient tells you almost nothing.
A clinical guide to reading HLA results: which alleles change prescribing today, why a coeliac-permissive type is not a diagnosis, and when a genome-derived HLA call must be confirmed before you act on it.
A clinician's guide to interpreting metabolizer phenotype labels, the gene–drug pairs with evidence strong enough to act on today, and why a genotype describes capacity rather than current enzyme activity.
A practical guide to interpreting a polygenic risk score report — how the number is built, how to convert a percentile into absolute risk, why the score may not apply to your patient at all, and why a high score usually changes timing and intensity rather than diagnosis.
Discover how your body naturally dissolves blood clots — and why this clot-busting power tends to weaken as we age, raising heart disease risk.
